🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In the elderly patients with hip fracture, some often take antiplatelet dru...
Status
Unknown
Location
Multiple Locations
Start Date
2020-01
Trial ID
NCT04165538
Treatments Being Tested
Ticagrelor is a potent and fast-acting P2Y12-ADP receptor antagonist recomm...
Status
Completed
Location
APHM
Start Date
2018-10-28
Trial ID
NCT03357874
Treatments Being Tested
It is a multi-center randomized clinical trial (RCT) which will enroll 3746...
Status
Unknown
Location
First Affiliated Hospital of Nanjing Medical University
Start Date
2018-02-03
Trial ID
NCT03234114
Treatments Being Tested
The use of platelet aggregation inhibitors, including aspirin and clopidogr...
Status
Completed
Location
Cardiovascular Institute and Fuwai Hospital
Start Date
2008-10
Trial ID
NCT01596738
Treatments Being Tested
Along with the current clinical trial, the efficacy and safety of 180 mg lo...
Status
Completed
Location
Kafr Elsheikh University Hospital
Start Date
2021-09-01
Trial ID
NCT06120725
Treatments Being Tested
The purpose of this study is to determine whether adjunction of intravenous...
Status
Terminated
Location
Centre Hospitalier de Pau
Start Date
2008-06
Trial ID
NCT00669149
The study goal is to determine the clinical benefit of percutaneous cathete...
Status
Completed
Location
Charité Universitätsmedizin Berlin, Klinik für Kardiologie, Angiologie und Intensivmedizin, Deutsches Herzzentrum der Charité, Campus Benjamin Franklin (CBF)
Start Date
2018-02-28
Trial ID
NCT03463317
Advanced kidney disease with it's associated heart and blood vessel problem...
Status
Completed
Location
St. Paul's Hospital
Start Date
2005-04
Trial ID
NCT00231803
This trial will enroll patients that have been diagnosed with minor stroke,...
Status
Completed
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2020-10-04
Trial ID
NCT04420351
Treatments Being Tested
The purpose of this study is to estimate the risk of bleeding with rivaroxa...
Status
Completed
Location
Multiple Locations
Start Date
2015-04-20
Trial ID
NCT02293395
Treatments Being Tested